Analyze Diet
Life (Basel, Switzerland)2026; 16(4); 626; doi: 10.3390/life16040626

Radiation in Veterinary Practice: Paradigm Shift Toward Precision and Curative Approaches.

Abstract: Ionizing radiation therapy has undergone a clear paradigm shift in veterinary oncology and inflammatory disease management, moving from mainly palliative use toward structured, curative treatment programs. This review synthesizes current evidence on key modalities used in veterinary practice, including external beam radiotherapy, brachytherapy, systemic targeted radionuclide therapy, stereotactic radiosurgery, stereotactic body radiotherapy, radiosynoviorthesis, and low-dose radiotherapy. Each modality is discussed in relation to its physical and biological basis, major isotopes or beam types, routes of delivery, target species such as dogs, cats, and horses, clinical indications, and global availability. Comparative analysis highlights differences in clinical acceptance, evidence strength, access, and cost. External beam radiotherapy and stereotactic techniques support curative tumor management, whereas radiosynoviorthesis and low-dose radiotherapy are effective for inflammatory and degenerative disorders. Despite ongoing progress, challenges remain in access, dosimetry standardization, and prospective evidence. Companion animals are also emphasized as valuable translational models, guiding future innovation and collaboration internationally.
Publication Date: 2026-04-08 PubMed ID: 42073435PubMed Central: PMC13117261DOI: 10.3390/life16040626Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Radiation therapy in veterinary medicine is evolving from mainly relieving symptoms to actively curing diseases using advanced, precise treatment techniques. This review summarizes various radiation methods for treating cancer and inflammatory conditions in animals like dogs, cats, and horses, discussing their principles, uses, and challenges.

Overview of Radiation Therapy Modalities in Veterinary Practice

  • External Beam Radiotherapy (EBRT):
    • Uses high-energy beams directed from outside the body to treat tumors.
    • Physical basis involves photons or particles targeting cancer cells with precision.
    • Applied mainly for curative cancer treatment in companion animals.
    • Widely available but may have limitations due to equipment cost and required expertise.
  • Brachytherapy:
    • Involves placing radioactive sources directly inside or near tumors.
    • Offers high local radiation doses while sparing surrounding tissues.
    • Used cautiously in veterinary settings due to complexity and safety requirements.
  • Systemic Targeted Radionuclide Therapy:
    • Delivers radioactive isotopes systemically, targeting cancer cells through molecular mechanisms.
    • Emerging modality in veterinary oncology for treating disseminated diseases.
    • Challenges include isotope handling and dosimetry accuracy.
  • Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT):
    • Precise delivery of high-dose radiation in few treatment sessions.
    • Allows curative intent therapies by minimizing damage to healthy tissues.
    • Growing clinical acceptance in veterinary oncology for solid tumors.
  • Radiosynoviorthesis:
    • Injection of radioactive materials into joints to treat inflammatory and degenerative joint disease.
    • Effective for managing chronic inflammation in dogs and horses.
    • Represents a valuable non-surgical intervention.
  • Low-dose Radiotherapy:
    • Uses low radiation doses focusing on reducing inflammation rather than killing cells.
    • Applied in inflammatory and degenerative conditions with promising results.

Clinical Indications and Target Species

  • Dogs, Cats, and Horses:
    • Primary focus of radiation therapies for both oncology and inflammatory diseases.
    • Disease types treated include tumors (e.g., sarcomas, carcinomas) and joint diseases.
    • Species-specific considerations affect choice of modality and dosing.

Comparative Analysis of Modalities

  • Clinical Acceptance and Evidence Strength:
    • EBRT and stereotactic methods have stronger evidence supporting curative outcomes.
    • Radiosynoviorthesis and low-dose RT have demonstrated efficacy in managing inflammatory conditions.
    • Systemic radionuclide therapy and brachytherapy are less commonly used but promising.
  • Access and Cost:
    • Advanced techniques like SRS and SBRT are limited by equipment and expertise availability.
    • Cost is a significant barrier, affecting widespread adoption in veterinary clinics.
    • Radiosynoviorthesis and low-dose RT are more accessible options for non-cancerous conditions.

Challenges and Future Directions

  • Access and Infrastructure:
    • Limited availability of advanced radiation therapy centers for veterinary patients globally.
    • Need for improved integration of these techniques in routine veterinary care.
  • Dosimetry Standardization:
    • Requirement for standardized dose calculation protocols to improve safety and efficacy.
    • Consistency across different institutions helps in comparing outcomes and optimizing treatments.
  • Prospective Evidence and Clinical Trials:
    • More controlled studies needed to validate long-term benefits and optimal protocols.
    • Data from prospective research will strengthen clinical guidelines.
  • Companion Animals as Translational Models:
    • Pets provide valuable insights applicable to human oncology and inflammatory disease treatments.
    • Encourages international collaboration for innovation and research in radiation therapies.

Cite This Article

APA
Mârza SM, Munteanu C, Lăcătuş R, Papuc I, Bora FD, Purdoiu RC. (2026). Radiation in Veterinary Practice: Paradigm Shift Toward Precision and Curative Approaches. Life (Basel), 16(4), 626. https://doi.org/10.3390/life16040626

Publication

ISSN: 2075-1729
NlmUniqueID: 101580444
Country: Switzerland
Language: English
Volume: 16
Issue: 4
PII: 626

Researcher Affiliations

Mârza, Sorin Marian
  • Clinical Sciences Department, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.
Munteanu, Camelia
  • Biology Section, Faculty of Agriculture, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.
Lăcătuş, Radu
  • Clinical Sciences Department, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.
Papuc, Ionel
  • Clinical Sciences Department, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.
Bora, Florin Dumitru
  • Laboratory of Chromatography, Advanced Horticultural Research Institute of Transylvania, Faculty of Horticulture and Business for Rural Development, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.
Purdoiu, Robert Cristian
  • Clinical Sciences Department, Faculty of Veterinary Medicine, University of Agricultural Sciences and Veterinary Medicine Cluj-Napoca, 3-5 Manastur Street, 400372 Cluj-Napoca, Romania.

Grant Funding

  • Internal project 6059 / University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca

Conflict of Interest Statement

The authors declare no conflicts of interest.

References

This article includes 132 references
  1. Lutz S, Jones J, Chow E. Role of Radiation Therapy in Palliative Care of the Patient with Cancer.. J. Clin. Oncol. 2014;32:2913–2919.
    doi: 10.1200/jco.2014.55.1143pmc: PMC4152720pubmed: 25113773google scholar: lookup
  2. Van Asselt N, Christensen N, Meier V, Rohrer Bley C, Laliberte S, Poirier V. Definitive-intent Intensity-modulated Radiation Therapy Provides Similar Outcomes to Those Previously Published for Definitive-intent Three-dimensional Conformal Radiation Therapy in Dogs with Primary Brain Tumors: A Multi-institutional Retrospective Study.. Vet. Radiol. Ultrasound. 2020;61:481–489.
    doi: 10.1111/vru.12868pmc: PMC7953428pubmed: 32356907google scholar: lookup
  3. Martin T, LaRue S, Griffin L, Leary D, Boss M. Retrospective Study Evaluating the Efficacy of Stereotactic Body Radiation Therapy for the Treatment of Confirmed or Suspected Primary Pulmonary Carcinomas in Dogs.. Vet. Comp. Oncol. 2023;21:656–664.
    doi: 10.1111/vco.12928pubmed: 37620018google scholar: lookup
  4. Nickoloff J, Boss M, Allen C, LaRue S. Translational Research in Radiation-Induced DNA Damage Signaling and Repair.. Transl. Cancer Res. 2017;6:S875.
    doi: 10.21037/tcr.2017.06.02pmc: PMC6298755pubmed: 30574452google scholar: lookup
  5. Rohrer Bley C, Meier V, Besserer J, Schneider U. Intensity-modulated Radiation Therapy Dose Prescription and Reporting: Sum and Substance of the International Commission on Radiation Units and Measurements Report 83 for Veterinary Medicine.. Vet. Radiol. Ultrasound. 2019;60:255–264.
    doi: 10.1111/vru.12722pubmed: 30786324google scholar: lookup
  6. Chargari C, Deutsch E, Blanchard P, Gouy S, Martelli H, Guérin F. Brachytherapy: An Overview for Clinicians.. CA Cancer J. Clin. 2019;69:386–401.
    doi: 10.3322/caac.21578pubmed: 31361333google scholar: lookup
  7. Rohrer Bley C, Meier V, Turek M, Besserer J, Unterhirkhers S. Stereotactic Radiation Therapy Planning, Dose Prescription and Delivery in Veterinary Medicine: A Systematic Review on Completeness of Reporting and Proposed Reporting Items.. Vet. Comp. Oncol. 2024;22:457–469.
    doi: 10.1111/vco.13011pubmed: 39367729google scholar: lookup
  8. Page M.J, McKenzie J.E, Bossuyt P.M, Boutron I, Hoffmann T.C, Mulrow C.D, Shamseer L, Tetzlaff J.M, Akl E.A, Brennan S.E. The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews.. BMJ. 2021;372:n71.
    doi: 10.1136/bmj.n71pmc: PMC8005924pubmed: 33782057google scholar: lookup
  9. Willows B, Melhus C. 2024 Guidelines for Reporting Radiation Therapy in Veterinary Medicine.. Vet. Radiol. Ultrasound. 2024;65:547–555.
    doi: 10.1111/vru.13396pubmed: 38899569google scholar: lookup
  10. Seo J, Son J, Cho Y, Park N, Kim D, Kim J. Kilovoltage Radiotherapy for Companion Animals: Dosimetric Comparison of 300 kV, 450 kV, and 6 MV X-Ray Beams.. J. Vet. Sci. 2018;19:550–556.
    pmc: PMC6070583pubmed: 29649856
  11. Buchholz J, Hagen R, Leo C, Ebling A, Roos M, Kaser-Hotz B. 3D Conformal Radiation Therapy for Palliative Treatment of Canine Nasal Tumors.. Vet. Radiol. Ultrasound. 2009;50:679–683.
  12. Yoshikawa H, Lafferty M, Griffin L, LaRue S. A Retrospective Study of Sinonasal Tumors in 182 Dogs Treated with Stereotactic Radiotherapy (3 × 10 Gy)(2010–2015). J. Vet. Intern. Med. 2023;37:2356–2367.
    doi: 10.1111/jvim.16838pmc: PMC10658520pubmed: 37688322google scholar: lookup
  13. Dolera M, Malfassi L, Carrara N, Finesso S, Marcarini S, Mazza G. Volumetric Modulated Arc (Radio) Therapy in Pets Treatment: The “La Cittadina Fondazione” Experience.. Cancers. 2018;10:30.
    doi: 10.3390/cancers10020030pmc: PMC5836062pubmed: 29364837google scholar: lookup
  14. Meier V, Czichon F, Walsh L, Rohrer Bley C. Can Volumetric Modulated Arc Radiation Therapy Reduce Organ at Risk Dose in Stage 4 Sinonasal Tumors in Dogs Treated with Boost Irradiation?. PLoS ONE. 2021;16:e0259112.
  15. Mason S, Pittaway C, Gil B, Russak O, Westlake K, Berlato D. Outcomes of Adjunctive Radiation Therapy for the Treatment of Mast Cell Tumors in Dogs and Assessment of Toxicity: A Multicenter Observational Study of 300 Dogs.. J. Vet. Intern. Med. 2021;35:2853–2864.
    doi: 10.1111/jvim.16264pmc: PMC8692218pubmed: 34672378google scholar: lookup
  16. Rossi F, Marconato L, Sabattini S, Cancedda S, Laganga P, Leone V. Comparison of Definitive-Intent Finely Fractionated and Palliative-Intent Coarsely Fractionated Radiotherapy as Adjuvant Treatment of Feline Microscopic Injection-Site Sarcoma.. J. Feline Med. Surg. 2019;21:65–72.
    doi: 10.1177/1098612X18758883pmc: PMC10814612pubmed: 29473768google scholar: lookup
  17. Cunha S, Carvalho L, Canary P, Reisner M, Corgozinho K, Souza H. Radiation Therapy for Feline Cutaneous Squamous Cell Carcinoma Using a Hypofractionated Protocol.. J. Feline Med. Surg. 2010;12:773–777.
    doi: 10.1016/j.jfms.2009.10.005pmc: PMC11135594pubmed: 20034827google scholar: lookup
  18. Gillen A, Mudge M, Caldwell F, Munsterman A, Hanson R, Brawner W. Outcome of External Beam Radiotherapy for Treatment of Noncutaneous Tumors of the Head in Horses: 32 Cases (1999–2015). J. Vet. Intern. Med. 2020;34:2808–2816.
    doi: 10.1111/jvim.15954pmc: PMC7694842pubmed: 33165966google scholar: lookup
  19. Vanhaezebrouck I, Scarpelli M. Companion Animals as a Key to Success for Translating Radiation Therapy Research into the Clinic.. Cancers 2023;15:3377.
    doi: 10.3390/cancers15133377pmc: PMC10341092pubmed: 37444487google scholar: lookup
  20. Fu D, Weng H, Mendez Valenzuela C, Vanhaezebrouck I, Plantenga J. Retrospective comparison of side effects and outcomes of three-dimensional conformal vs. intensity-modulated radiation therapy in the palliative-intent treatment (4 Gy× 5 daily fractions) of canine intranasal tumors (2010–2017). Front. Vet. Sci. 2023;10:1011949.
    doi: 10.3389/fvets.2023.1011949pmc: PMC10043394pubmed: 36998642google scholar: lookup
  21. Ahrens C, Beatrice L, Meier V, Rohrer Bley C. Radiation Toxicity Grading after Chemoradiotherapy of Canine Urinary Tract Carcinomas: Comparing VRTOG to VRTOG_v2.0.. Vet. Comp. Oncol. 2024;22:255–264.
    doi: 10.1111/vco.12973pubmed: 38544415google scholar: lookup
  22. Klueter S, Krastel D, Ludewig E, Reischauer A, Heinicke F, Pohlmann S. High-dose-rate Brachytherapy for Intranasal Tumours in Dogs: Results of a Pilot Study.. Vet. Comp. Oncol. 2006;4:218–231.
  23. Hauser A, Thorsen L, Boss M, Martin TW. A Retrospective Study Evaluating the Outcomes of Conventionally Fractionated Radiation Therapy as a Treatment for Infiltrative Lipomas in Twenty-One Dogs.. Vet. Comp. Oncol. 2024;22:523–530.
    doi: 10.1111/vco.13001pubmed: 39288821google scholar: lookup
  24. Yun C-O, Choi M, Hwang G, Huh C, Lee H.C, Hwang T.S. Radiation Therapy Trends in Dogs and Cats at a Korean Veterinary Oncology Center, 2020–2023.. J. Vet. Sci. 2025;26:e85.
    doi: 10.4142/jvs.25124pmc: PMC12703919pubmed: 41332005google scholar: lookup
  25. Gieger T.L. Radiation Therapy for Brain Tumors in Dogs and Cats.. Vet. Clin. N. Am. Small Anim. Pract. 2025;55:67–80.
    doi: 10.1016/j.cvsm.2024.07.007pubmed: 39393930google scholar: lookup
  26. Jiang Y, Meng N, Wang J, Jiang P, Yuan H, Liu C. CT-Guided Iodine-125 Seed Permanent Implantation for Recurrent Head and Neck Cancers.. Radiat. Oncol. 2010;5:68.
    doi: 10.1186/1748-717X-5-68pmc: PMC2919543pubmed: 20673340google scholar: lookup
  27. Bloch J, Rogers K, Walker M, Dawson J, Wilson-Robles H. Treatment of Feline Injection-Site Sarcoma with Surgery and Iridium-192 Brachytherapy: Retrospective Evaluation of 22 Cats.. J. Feline Med. Surg. 2020;22:313–321.
    doi: 10.1177/1098612X19844345pmc: PMC10814673pubmed: 30982391google scholar: lookup
  28. Zhang W, Luo J, Liu Q, Ma J, Qu X, Yang M. Brachytherapy with Iodine-125 Seeds Strand for Treatment of Main Portal Vein Tumor Thrombi: An Experimental Study in a Rabbit Model.. Am. J. Cancer Res. 2016;6:587–597.
    pmc: PMC4851839pubmed: 27152237
  29. Vanhaezebrouck I.F, Bentley R.T, Georgiades A, Arnold S, Young J.A, Claus N, Danaher L, Klutzke J.B, Scarpelli M.L. Implementing Neurosurgery and Cesium-131 Brachytherapy in Veterinary Medicine: A Veterinary Case Study with a Review of Clinical Usage of Cesium-131 for Brain Tumors in Human Patients and Opportunities for Translational Research.. Radiation. 2025;5:13.
    doi: 10.3390/radiation5020013google scholar: lookup
  30. Watkins C, Hayes J, Bryant J, Walsh T, Skidmore T. High Dose Rate Brachytherapy in the Treatment of Companion Animals at a Veterinary Center with Dedicated Iridium-192 HDR Brachytherapy.. Brachytherapy. 2019;18:S82–S83.
  31. Tian Q, Zhu H, Li H. Interstitial Brachytherapy of Oral Squamous Cell Carcinoma with Ultrasound-Guided Iodine-125 Radioactive Seed Implantation. Eur. Rev. Med. Pharmacol. Sci. 2018;22:1733–1739.
    pubmed: 29630112
  32. Donecker J, Stevenson N. Radiosynoviorthesis. .
  33. Xue G, Feng Y, Li J. Significance of 125I Radioactive Seed Implantation on Growth Differentiation Factor and Programmed Death Receptor-1 during Treatment of Oral Cancer. World J. Clin. Cases 2020;8:874–885.
    doi: 10.12998/wjcc.v8.i5.874pmc: PMC7062616pubmed: 32190624google scholar: lookup
  34. Hollis A. High Dose Rate Brachytherapy for the Treatment of Skin Tumours in Humans and Animals. Equine Vet. Educ. 2022;34:499–500.
    doi: 10.1111/eve.13596google scholar: lookup
  35. Serafini A. Therapy of Metastatic Bone Pain. J. Nucl. Med. 2001;42:895–906.
    pubmed: 11390554
  36. Crișan G, Moldovean-Cioroianu N, Timaru D, Andrieș G, Căinap C, Chiș V. Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade. Int. J. Mol. Sci. 2022;23:5023.
    doi: 10.3390/ijms23095023pmc: PMC9103893pubmed: 35563414google scholar: lookup
  37. Liberal F, Tavares A, Tavares J P. Palliative Treatment of Metastatic Bone Pain with Radiopharmaceuticals: A Perspective beyond Strontium-89 and Samarium-153. Appl. Radiat. Isot. 2016;110:87–99.
  38. Lass P, Scheffler J. 153Sm-EDTMP and 89SrCl2 in a Dog with Spontaneous Osteosarcoma. Eur. J. Nucl. Med. Mol. Imaging 2002;29:1414.
    doi: 10.1007/s00259-002-0894-2pubmed: 12271428google scholar: lookup
  39. Selting K, Simon J, Lattimer J, Ketring A, Axiak-Bechtel S, Frank K. Phase I Evaluation of CycloSam®(Sm-153-DOTMP) Bone Seeking Radiopharmaceutical in Dogs with Spontaneous Appendicular Osteosarcoma. Vet. Radiol. Ultrasound 2023;64:982–991.
    doi: 10.1111/vru.13274pubmed: 37431065google scholar: lookup
  40. De Voogt C, Williams L, Stammeleer L, Peremans K, Vandermeulen E, Paepe D. Radioiodine Treatment in Hyperthyroid Cats: Insights into the Characteristics of Owners and Their Cats, and Owner Motivation and Perceptions. J. Feline Med. Surg. 2023;25:1098612X221150191.
    doi: 10.1177/1098612X221150191pmc: PMC10812082pubmed: 36744573google scholar: lookup
  41. Chow J, White J. Radioactive Iodine Dose and Survival in Cats with Hyperthyroidism (2015–2020). J. Feline Med. Surg. 2022;24:1001–1007.
    doi: 10.1177/1098612X211056837pmc: PMC10812325pubmed: 34730466google scholar: lookup
  42. Zemczak A, Kołodziej M, Gut P, Królicki L, Kos-Kudła B, Kamiński G. Effect of Peptide Receptor Radionuclide Therapy (PRRT) with Tandem Isotopes [90Y] Y/[177Lu] Lu-DOTATATE in Patients with Disseminated Neuroendocrine Tumours Depending on [18F] FDG PET/CT Qualification in Polish Multicentre Experience Do We Need [18F] FDG PET/CT for Qualification to PRRT?. Endokrynol. Pol. 2020;71:240–248.
    pubmed: 32293704
  43. Morsink N.C., Nijsen J.F.W., Grinwis G.C.M., Hesselink J.W., Kirpensteijn J., Van Nimwegen S.A.. Intratumoral Injection of Holmium-166 Microspheres as Neoadjuvant Therapy of Soft Tissue Sarcomas in Dogs. Front. Vet. Sci. 2022;9:1015248.
    doi: 10.3389/fvets.2022.1015248pmc: PMC9664058pubmed: 36387397google scholar: lookup
  44. Maitz C, Bryan J. The Role of Companion Animal Models in Radiopharmaceutical Development and Translation. Vet. Comp. Oncol. 2024;22:165–173.
    doi: 10.1111/vco.12969pubmed: 38439693google scholar: lookup
  45. Morsink C, Klaassen N, Van De Maat G, Boswinkel M, Arranja A, Bruggink R, Van Houwelingen I, Schaafsma I, Hesselink J.W., Nijsen F. Quantitative CT Imaging and Radiation-Absorbed Dose Estimations of 166Ho Microspheres: Paving the Way for Clinical Application. Eur. Radiol. Exp. 2024;8:116.
    doi: 10.1186/s41747-024-00511-8pmc: PMC11473764pubmed: 39400769google scholar: lookup
  46. Krzemiński M., Lass P., Teodorczyk J., Krajka J.. Veterinary Nuclear Medicine. Nucl. Med. Rev. Cent. East. Eur. 2004;7:177–182.
    pubmed: 15968607
  47. Fenger J, London C, Kisseberth W. Canine Osteosarcoma: A Naturally Occurring Disease to Inform Pediatric Oncology. ILAR J. 2014;55:69–85.
    doi: 10.1093/ilar/ilu009pubmed: 24936031google scholar: lookup
  48. Pasciak A, Manupipatpong S, Hui F, Gainsburg L, Krimins R, Zink M. Yttrium-90 Radioembolization as a Possible New Treatment for Brain Cancer: Proof of Concept and Safety Analysis in a Canine Model. EJNMMI Res. 2020;10:96.
    doi: 10.1186/s13550-020-00679-1pmc: PMC7431501pubmed: 32804262google scholar: lookup
  49. Del Portillo I, Sesanto C, Parys M, Serra J. Radiation Therapy in Veterinary Medicine: A Practical Review. Companion Anim. 2020;25:1–15.
    doi: 10.12968/coan.2019.0056google scholar: lookup
  50. Bloomfield R. Stereotactic Radiation Therapy in Veterinary Medicine. Can. Vet. J. 2015;56:95–96.
    pmc: PMC4266068pubmed: 25565724
  51. Mariani C, Schubert T, House R, Wong M, Hopkins A, Barnes Heller H. Frameless Stereotactic Radiosurgery for the Treatment of Primary Intracranial Tumours in Dogs. Vet. Comp. Oncol. 2015;13:409–423.
    doi: 10.1111/vco.12056pubmed: 24007303google scholar: lookup
  52. Gieger T, Nolan M. Linac-based Stereotactic Radiation Therapy for Canine Non-lymphomatous Nasal Tumours: 29 Cases (2013–2016). Vet. Comp. Oncol. 2018;16:e68–e75.
    doi: 10.1111/vco.12334pubmed: 28741887google scholar: lookup
  53. Gualtieri P, Martin T, Leary D, Lana S, LaRue S, Boss M. Canine Salivary Gland Carcinoma Treated with Stereotactic Body Radiation Therapy: A Retrospective Case Series. Front. Vet. Sci. 2023;10:1202265.
    doi: 10.3389/fvets.2023.1202265pmc: PMC10333581pubmed: 37441554google scholar: lookup
  54. Griffin L, Nolan M, Selmic L, Randall E, Custis J, LaRue S. Stereotactic Radiation Therapy for Treatment of Canine Intracranial Meningiomas. Vet. Comp. Oncol. 2016;14:e158–e170.
    doi: 10.1111/vco.12129pubmed: 25524449google scholar: lookup
  55. Arslan A, Sengul B. Comparison of Radiotherapy Techniques with Flattening Filter and Flattening Filter-Free in Lung Radiotherapy According to the Treatment Volume Size. Sci. Rep. 2020;10:8983.
    doi: 10.1038/s41598-020-66079-6pmc: PMC7265285pubmed: 32488150google scholar: lookup
  56. He D, Zhu Z, Zhang X, Zhang Y, Hong J, Shi T. Evaluating the Influence of 6MV and 10MV Photon Beams on Cervical Cancer Volumetric-Modulated Arc Therapy Plans. Technol. Health Care. 2022;30:1515–1523.
    doi: 10.3233/THC-213617pubmed: 35661033google scholar: lookup
  57. Trageser E, Martin T, Burdekin B, Hart C, Leary D, LaRue S, Boss M. Efficacy of Stereotactic Radiation Therapy for the Treatment of Confirmed or Presumed Canine Glioma. Vet. Comp. Oncol. 2023;21:578–586.
    doi: 10.1111/vco.12920pubmed: 37423611google scholar: lookup
  58. Wormhoudt T, Boss M, Lunn K, Griffin L, Leary D, Dowers K. Stereotactic Radiation Therapy for the Treatment of Functional Pituitary Adenomas Associated with Feline Acromegaly. J. Vet. Intern. Med. 2018;32:1383–1391.
    doi: 10.1111/jvim.15212pmc: PMC6060317pubmed: 29782043google scholar: lookup
  59. Kruckman-Gatesy C, Ames M, Griffin L, Boss M, Rao S, Leary D. A Retrospective Analysis of Stereotactic Body Radiation Therapy for Canine Heart Base Tumors: 26 Cases. J. Vet. Cardiol. 2020;27:62–77.
    doi: 10.1016/j.jvc.2020.01.002pubmed: 32078943google scholar: lookup
  60. Nolan M, Griffin L, Custis J, LaRue S. Stereotactic Body Radiation Therapy for Treatment of Injection-Site Sarcomas in Cats: 11 Cases (2008–2012). J. Am. Vet. Med. Assoc. 2013;243:526–531.
    doi: 10.2460/javma.243.4.526pubmed: 23902446google scholar: lookup
  61. Altwal J., Lee B., Boss M., LaRue S.M., Martin T.W.. Outcomes of 35 Dogs with Craniomaxillofacial Osteosarcoma Treated with Stereotactic Body Radiation Therapy. Vet. Comp. Oncol. 2024;22:125–135.
    doi: 10.1111/vco.12960pubmed: 38246695google scholar: lookup
  62. Chan Q.Y.P., Morrow D., Lurie D.. Canine Primary Liver Tumors Treated with Stereotactic Body Radiation Therapy: A Case Series. Vet. Radiol. Ultrasound. 2024;65:121–129.
    doi: 10.1111/vru.13336pubmed: 38279767google scholar: lookup
  63. Linder T., Wakamatsu C., Jacovino J., Hsieh Y.H., Mueller M.. Stereotactic Body Radiation Therapy as an Alternative to Adrenalectomy for the Treatment of Pheochromocytomas in 8 Dogs. Vet. Comp. Oncol. 2023;21:45–53.
    doi: 10.1111/vco.12859pubmed: 36149359google scholar: lookup
  64. Thorsen L., Law K., Walz J., Coll V.M., Naramor A., Maitz C., Kubicek L., Thorsen Z., Gutti J.R., Takada M.. Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs. Vet. Comp. Oncol. 2026;24:150–159.
    doi: 10.1111/vco.70035pmc: PMC12875752pubmed: 41410158google scholar: lookup
  65. Zwingenberger A., Pollard R., Taylor S., Chen R., Nunley J., Kent M.. Perfusion and Volume Response of Canine Brain Tumors to Stereotactic Radiosurgery and Radiotherapy. J. Vet. Intern. Med. 2016;30:827–835.
    doi: 10.1111/jvim.13945pmc: PMC4867273pubmed: 27149650google scholar: lookup
  66. Lai Y.E., Kent M.S., Nolan M.W., Fu D., Looper J.S.. A Multi-Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024). Vet. Comp. Oncol. 2026:vco.70041.
    doi: 10.1111/vco.70041pubmed: 41491665google scholar: lookup
  67. Fukuyama Y., Hosoya K., Kim S., Sung K., Deguchi T., Shimbo G., Sasaoka K., Kinoshita R., Takiguchi M.. Outcomes and Prognostic Factors in Dogs With Presumed Intracranial Gliomas Treated With Definitive-Intent Intensity Modulated Radiation Therapy: 55 Cases (2014–2023). Vet. Comp. Oncol. 2025;23:616–628.
    doi: 10.1111/vco.70017pubmed: 40852884google scholar: lookup
  68. Lee B., LaRue S., Seguin B., Griffin L., Prebble A., Martin T.. Safety and Efficacy of Stereotactic Body Radiation Therapy (SBRT) for the Treatment of Canine Thyroid Carcinoma. Vet. Comp. Oncol. 2020;18:843–853.
    doi: 10.1111/vco.12625pubmed: 32515526google scholar: lookup
  69. Unterkirhers S., Meier V.S., Bley C.R.. Brain Dose–Volume Thresholds and Survival in Dogs With Intracranial Tumours Treated With the 10 × 4 Gy Radiotherapy Schedule: A Combined Analysis of Two Trials. Vet. Comp. Oncol. 2026;24:177–185.
    doi: 10.1111/vco.70038pmc: PMC12875757pubmed: 41420297google scholar: lookup
  70. Geiger R., Mankin J., Volk H.A., De Decker S., Van Asselt N., Randhawa K., Ehling T., Maitz C.A., Naramor A., Coates J.R.. Comparison of Survival After Treatment of Presumed Intracranial Meningioma by Radiotherapy or Surgery in 285 Dogs. J. Vet. Intern. Med. 2025;39:jvim70011.
    doi: 10.1111/jvim.70011pmc: PMC11836666pubmed: 39968764google scholar: lookup
  71. Carter G., Ogilvie G., Mohammadian L., Bergman P., Lee R., Proulx D.. CyberKnife Stereotactic Radiotherapy for Treatment of Primary Intracranial Tumors in Dogs. J. Vet. Intern. Med. 2021;35:1480–1486.
    doi: 10.1111/jvim.16086pmc: PMC8163137pubmed: 33755255google scholar: lookup
  72. Gualtieri P., Lee B.-I., Beeney A., Hart C., Leary D., Martin T., Boss M.-K.. Response of Spontaneous Oral Tumors in Canine Cancer Patients Treated with Stereotactic Body Radiation Therapy (SBRT). Radiat. Res. 2024;202.
    doi: 10.1667/RADE-24-00079.1pmc: PMC12767549pubmed: 39478420google scholar: lookup
  73. Morris Z.S., Demaria S., Monjazeb A.M., Formenti S.C., Weichselbaum R.R., Welsh J., Enderling H., Schoenfeld J.D., Brody J.D., McGee H.M.. Proceedings of the National Cancer Institute Workshop on Combining Immunotherapy with Radiotherapy: Challenges and Opportunities for Clinical Translation. Lancet Oncol. 2025;26:e152–e170.
  74. Mortier J., Maddox T., Blackwood L., La Fontaine M., Busoni V.. Dynamic Contrast-Enhanced Computed Tomography Perfusion Parameters of Canine Suspected Brain Tumors at Baseline and during Radiotherapy Might Be Different Depending on Tumor Location but Not Associated with Survival. Front. Vet. Sci. 2023;10:1179762.
    doi: 10.3389/fvets.2023.1179762pmc: PMC10175699pubmed: 37187932google scholar: lookup
  75. Gualtieri P, Prebble A, Martin T, Griffin RJ, Boss M-K, Leary DL. Lattice Radiation Therapy for Canine Sinonasal Carcinoma: Feasibility Study of Spatially Fractionated Radiotherapy Using Volumetric Modulated Arc Therapy. BMC Vet. Res. 2025;21:598.
    doi: 10.1186/s12917-025-05030-1pmc: PMC12512791pubmed: 41074083google scholar: lookup
  76. Kim S, Kim E, Ryu M-O, Seo K, Yoon J, Choi J. Computed Tomography Perfusion in Predicting Radiation Therapy Response in Dogs and a Cat with Head and Neck Tumors. J. Vet. Intern. Med. 2026;40:aalaf025.
    doi: 10.1093/jvimsj/aalaf025pmc: PMC12881964pubmed: 41742522google scholar: lookup
  77. Kampen W, Boddenberg-Pätzold B, Fischer M, Gabriel M, Klett R, Konijnenberg M. The EANM Guideline for Radiosynoviorthesis. Eur. J. Nucl. Med. Mol. Imaging 2022;49:681–708.
    doi: 10.1007/s00259-021-05541-7pmc: PMC8803784pubmed: 34671820google scholar: lookup
  78. van der Zant F, Boer R, Moolenburgh J, Jahangier Z, Bijlsma J, Jacobs J. Radiation Synovectomy with Yttrium-90, Rhenium-186 and Erbium-169: A Systematic Literature Review with Meta-Analyses. Clin. Exp. Rheumatol. 2007;25:656–666.
    pubmed: 19327243
  79. Donecker J, Lattimer JC, Gaschen L, Aulakh KS. Safety and Clinical Response Following a Repeat Intraarticular Injection of Tin-117m (117mSn) Colloid in Dogs with Elbow Osteoarthritis. Vet. Med. Res. Rep. 2021;12:325–335.
    doi: 10.2147/VMRR.S345144pmc: PMC8691448pubmed: 34950571google scholar: lookup
  80. Caballero Motta L, Anzola Alfaro A, Janta I, Molina Collada J, Henao Y, Pérez Pascual R. Radiosynovectomy in Routine Care: An Old Tool with Modern Applications. Ther. Adv. Musculoskelet. Dis. 2021;13:1759720X211055309.
    doi: 10.1177/1759720X211055309pmc: PMC8641112pubmed: 34868355google scholar: lookup
  81. Donecker J, Fabiani M, Gaschen L, Aulakh K. Treatment Response in Dogs with Naturally Occurring Grade 3 Elbow Osteoarthritis Following Intra-Articular Injection of 117mSn (Tin) Colloid. PLoS ONE 2021;16:e0254613.
  82. Lattimer J, Selting K, Lunceford J, Holland J, Simon J, Stevenson N. Intraarticular Injection of a Tin-117 m Radiosynoviorthesis Agent in Normal Canine Elbows Causes No Adverse Effects. Vet. Radiol. Ultrasound 2019;60:567–574.
    doi: 10.1111/vru.12757pubmed: 31155782google scholar: lookup
  83. Bielińska A, Korkosz M, Gąsowski J, Tomaszuk M, Staszczak-Sowa A, Kwaśny-Krochin B. Yttrium-90 Distribution Following Radiosynoviorthesis of the Knee Joint in Rheumatoid Arthritis Patients: A SPECT/CT Study. Ann. Nucl. Med. 2014;28:688–692.
    doi: 10.1007/s12149-014-0827-8pmc: PMC4135179pubmed: 24595462google scholar: lookup
  84. Klett R, Lange U, Haas H, Voth M, Pinkert J. Radiosynoviorthesis of Medium-Sized Joints with Rhenium-186-Sulphide Colloid: A Review of the Literature. Rheumatol. Oxf. 2007;46:1531–1537.
    doi: 10.1093/rheumatology/kem155pubmed: 17596287google scholar: lookup
  85. Vereb M, Liepe K, Fischer M, Kaliska L, Noskovicova L, Balogova S. Radiosynoviorthesis of Acromioclavicular Joint Using 169Er-Citrate: Prospective Evaluation of Efficacy. Nucl. Med. Rev. Cent. East. Eur. 2018;21:26–31.
    pubmed: 29319135
  86. Lattimer J, Fabiani M, Gaschen L, Aulakh K, Selting K. Clinical Effectiveness and Safety of Intraarticular Administration of a117m Tin Radiocolloid (Synovetin OATM) for Treatment of Early and Intermediate Grade Osteoarthritis of the Elbow in a Dose Finding Study Conducted in 44 Dogs. Vet. Radiol. Ultrasound 2023;64:351–359.
    doi: 10.1111/vru.13198pubmed: 36507585google scholar: lookup
  87. Desaulniers M, Paquette M, Dubreuil S, Senta H, Lavallée É, Thorne J. Safety and Efficacy of Radiosynoviorthesis: A Prospective Canadian Multicenter Study. J. Nucl. Med. 2024;65:1095–1100.
    doi: 10.2967/jnumed.123.267297pubmed: 38754957google scholar: lookup
  88. Bendele A, Doerr C, Gonzales G, Menardi R, Schreiber E, Stevenson N. Evidence of Osteoarthritis Disease Modification with a Sn-117m Microparticle Device: A Review and Validation in Mammalian Models. Front. Vet. Sci. 2025;12:1621296.
    doi: 10.3389/fvets.2025.1621296pmc: PMC12290414pubmed: 40717911google scholar: lookup
  89. Aulakh K, Lopez M, Hudson C, Gaschen L, Fabiani M, Beale B. Prospective Clinical Evaluation of Intra-Articular Injection of Tin-117m (117mSn) Radiosynoviorthesis Agent for Management of Naturally Occurring Elbow Osteoarthritis in Dogs: A Pilot Study. Vet. Med. Auckl. 2021;12:117–128.
    doi: 10.2147/VMRR.S295309pmc: PMC8187093pubmed: 34113552google scholar: lookup
  90. Arno M, Stevenson N, Smith C, Donecker J. Update and Extension of Release Criteria for Canine 117mSn Treatments. Health Phys 2023;124:391–396.
  91. Ahmad I, Nisar H. Dosimetry Perspectives in Radiation Synovectomy. Phys. Med. 2018;47:64–72.
    pubmed: 29609820
  92. Arno M.G., Barnhard J.A., Webb K.R., Smith C, Donecker J, Menardi R, Brunke M.W. Tin-117m Radiosynoviorthesis Safely and Effectively Manages Canine Osteoarthritis with Minimal Radiation Exposure: A Narrative Review. J. Am. Vet. Med. Assoc. 2026:1–5.
    doi: 10.2460/javma.25.08.0564pubmed: 41499964google scholar: lookup
  93. Rödel F, Keilholz L, Herrmann M, Sauer R, Hildebrandt G. Radiobiological Mechanisms in Inflammatory Diseases of Low-Dose Radiation Therapy. Int. J. Radiat. Biol. 2007;83:357–366.
    doi: 10.1080/09553000701317358pubmed: 17487675google scholar: lookup
  94. Weissmann T, Rückert M, Zhou J, Seeling M, Lettmaier S, Donaubauer A. Low-Dose Radiotherapy Leads to a Systemic Anti-Inflammatory Shift in the Pre-Clinical K/BxN Serum Transfer Model and Reduces Osteoarthritic Pain in Patients. Front. Immunol. 2022;13:777792.
    pmc: PMC8763318pubmed: 35046940
  95. Rödel F, Hofmann D, Auer J, Keilholz L, Röllinghoff M, Sauer R. The Anti-Inflammatory Effect of Low-Dose Radiation Therapy Involves a Diminished CCL20 Chemokine Expression and Granulocyte/Endothelial Cell Adhesion. Strahlenther. Onkol. 2008;184:41–47.
    doi: 10.1007/s00066-008-1776-8pubmed: 18188522google scholar: lookup
  96. Arenas M, Gil F, Gironella M, Hernández V, Jorcano S, Biete A. Anti-Inflammatory Effects of Low-Dose Radiotherapy in an Experimental Model of Systemic Inflammation in Mice. Int. J. Radiat. Oncol. Biol. Phys. 2006;66:560–567.
    doi: 10.1016/j.ijrobp.2006.06.004pubmed: 16965998google scholar: lookup
  97. Glasow A, Patties I, Priest N, Mitchel R, Hildebrandt G, Manda K. Dose and Dose Rate-Dependent Effects of Low-Dose Irradiation on Inflammatory Parameters in ApoE-Deficient and Wild Type Mice. Cells 2021;10:3251.
    doi: 10.3390/cells10113251pmc: PMC8625495pubmed: 34831473google scholar: lookup
  98. Frey B, Hehlgans S, Rödel F, Gaipl U. Modulation of Inflammation by Low and High Doses of Ionizing Radiation: Implications for Benign and Malign Diseases. Cancer Lett. 2015;368:230–237.
    doi: 10.1016/j.canlet.2015.04.010pubmed: 25888451google scholar: lookup
  99. Pampena R, Palmieri T, Kyrgidis A, Ramundo D, Iotti C, Lallas A. Orthovoltage Radiotherapy for Nonmelanoma Skin Cancer (NMSC): Comparison between 2 Different Schedules. J. Am. Acad. Dermatol. 2016;74:341–347.
    doi: 10.1016/j.jaad.2015.09.031pubmed: 26589877google scholar: lookup
  100. Dove A, Cmelak A, Darrow K, McComas K, Chowdhary M, Beckta J. The Use of Low-Dose Radiation Therapy in Osteoarthritis: A Review. Int. J. Radiat. Oncol. Biol. Phys. 2022;114:203–220.
    doi: 10.1016/j.ijrobp.2022.04.029pubmed: 35504501google scholar: lookup
  101. . Radiotherapy of Benign Diseases. DEGRO; Berlin, Germany: 2022. Version 3.0.
  102. Rossi F, Cancedda S, Leone V, Rohrer Bley C, Laganga P. Megavoltage Radiotherapy for the Treatment of Degenerative Joint Disease in Dogs: Results of a Preliminary Experience in an Italian Radiotherapy Centre. Front. Vet. Sci. 2018;5:74.
    doi: 10.3389/fvets.2018.00074pmc: PMC5903029pubmed: 29692993google scholar: lookup
  103. Kapatkin A, Nordquist B, Garcia T, Griffin M, Theon A, Kim S. Effect of Single Dose Radiation Therapy on Weight-Bearing Lameness in Dogs with Elbow Osteoarthritis. Vet. Comp. Orthop. Traumatol. 2016;29:338–343.
    pubmed: 27432273
  104. . Recommendations for Using Radiotherapy for Benign Disease in the UK. Royal College of Radiologists Guidance; London, UK: 2023.
  105. Solis D, Mayer M. Low Dose Radiation Therapy for the Treatment of Refractory Canine Osteoarthritis. Can. Vet. J. 2022;63:871–874.
    pmc: PMC9282549pubmed: 35919468
  106. Minten M, Mahler E, Leseman-Hoogenboom M, Boks S, Kloppenburg M, Leer J. OP0058 Low-Dose Radiation Therapy as Treatment for Hand and Knee Osteoarthritis: Two Double-Blinded Rct’s. Ann. Rheum. Dis. 2018;77:79–80.
  107. Frezoulis P, Harper A, Mason S. Use of a Cyclical Hypofractionated Radiotherapy Regime (‘QUAD Shot’) for the Treatment of Feline Sinonasal Carcinomas. J. Feline Med. Surg. 2022;24:1212–1218.
    doi: 10.1177/1098612X211070737pmc: PMC10812364pubmed: 35125013google scholar: lookup
  108. Ma C. Physics and Dosimetric Principles of SRS and SBRT. Mathews J. Cancer Sci. 2019;4:1–16.
    doi: 10.30654/mjcs.10022google scholar: lookup
  109. Feng Y, Lawrence J, Cheng K, Montgomery D, Forrest L, Mclaren D. Invited Review Image Registration in Veterinary Radiation Oncology: Indications, Implications, and Future Advances. Vet. Radiol. Ultrasound. 2016;57:113–123.
    doi: 10.1111/vru.12342pubmed: 26777133google scholar: lookup
  110. Jeraj R, Bradshaw T, Simončič U. Molecular Imaging to Plan Radiotherapy and Evaluate Its Efficacy. J. Nucl. Med. 2015;56:1752–1765.
    doi: 10.2967/jnumed.114.141424pubmed: 26383148google scholar: lookup
  111. Jaffray D, Das S, Jacobs P, Jeraj R, Lambin P. How Advances in Imaging Will Affect Precision Radiation Oncology. Int. J. Radiat. Oncol. Biol. Phys. 2018;101:292–298.
    doi: 10.1016/j.ijrobp.2018.01.047pubmed: 29726358google scholar: lookup
  112. Moon A, Heller H, Forrest L. Image-Guided Stereotactic Radiotherapy in 4 Dogs with Intracranial Neoplasia. Can. Vet. J. 2016;57:519–522.
    pmc: PMC4827744pubmed: 27152041
  113. Kelsey K, Gieger T, Nolan M. Single Fraction Stereotactic Radiation Therapy (Stereotactic Radiosurgery) Is a Feasible Method for Treating Intracranial Meningiomas in Dogs. Vet. Radiol. Ultrasound. 2018;59:632–638.
    doi: 10.1111/vru.12636pubmed: 29873144google scholar: lookup
  114. Magalhaes T, Benoit J, Néčová S, North S, Queiroga F. Outcome after Radiation Therapy in Canine Intracranial Meningiomas or Gliomas. In Vivo 2021;35:1117–1123.
    doi: 10.21873/invivo.12357pmc: PMC8045087pubmed: 33622909google scholar: lookup
  115. Iseri T, Horikirizono H, Abe M, Itoh H, Sunahara H, Nemoto Y. Outcomes of Megavoltage Radiotherapy for Canine Intranasal Tumors and Its Relationship to Clinical Stages. Open Vet. J. 2022;12:383–390.
    doi: 10.5455/OVJ.2022.v12.i3.12pmc: PMC9270932pubmed: 35821780google scholar: lookup
  116. Formenti S, Demaria S. Systemic Effects of Local Radiotherapy. Lancet Oncol. 2009;10:718–726.
  117. Boss M, Watts R, Harrison L, Hopkins S, Chow L, Trageser E. Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy. Int. J. Mol. Sci. 2022;23:826.
    doi: 10.3390/ijms23020826pmc: PMC8775899pubmed: 35055015google scholar: lookup
  118. Bradshaw T, Bowen S, Deveau M, Kubicek L, White P, Bentzen S. Molecular Imaging Biomarkers of Resistance to Radiation Therapy for Spontaneous Nasal Tumors in Canines. Int. J. Radiat. Oncol. Biol. Phys. 2015;91:787–795.
  119. Chakraborty S, Balogh L, Das T, Polyák A, Andócs G, Máthé D. Evaluation of; 177Lu-EDTMP in Dogs with Spontaneous Tumor Involving Bone: Pharmacokinetics, Dosimetry and Therapeutic Efficacy. Curr. Radiopharm. 2016;9:64–70.
  120. Atun R, Jaffray D, Barton M, Bray F, Baumann M, Vikram B. Expanding Global Access to Radiotherapy. Lancet Oncol 2015;16:1153–1186.
    doi: 10.1016/S1470-2045(15)00222-3pubmed: 26419354google scholar: lookup
  121. Wong J, Huang V, Giambattista J, Teke T, Kolbeck C, Giambattista J. Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours. Front Oncol 2021;11:626499.
    doi: 10.3389/fonc.2021.626499pmc: PMC8215371pubmed: 34164335google scholar: lookup
  122. Leary D, Basran PS. The Role of Artificial Intelligence in Veterinary Radiation Oncology. Vet Radiol Ultrasound 2022;63:903–912.
    doi: 10.1111/vru.13162pubmed: 36514233google scholar: lookup
  123. Aumarm W, Theerapan W, Suntiwong S, Dechaworakul K, Wibulchan W, Thongsawad S. Automated Knowledge-Based Radiation Treatment Planning in Canine and Feline Nasal Tumors. Vet Radiol Ultrasound 2025;66:e70064.
    doi: 10.1111/vru.70064pubmed: 40726146google scholar: lookup
  124. Li S, Yu F, Gao Y. The Application of Artificial Intelligence in Veterinary Oncology: A Scoping Review. BMC Vet Res 2025;22:28.
    doi: 10.1186/s12917-025-05192-ypmc: PMC12817679pubmed: 41388461google scholar: lookup
  125. Maitre P, Krishnatry R, Chopra S, Gondhowiardjo S, Likonda B, Hussain Q. Modern Radiotherapy Technology: Obstacles and Opportunities to Access in Low-and Middle-Income Countries. JCO Glob Oncol 2022;8:e2100376.
    doi: 10.1200/GO.21.00376pmc: PMC9812473pubmed: 35839434google scholar: lookup
  126. Janopaul-Naylor J, Shen Y, Qian D, Buchwald Z. The Abscopal Effect: A Review of Pre-Clinical and Clinical Advances. Int J Mol Sci 2021;22:11061.
    doi: 10.3390/ijms222011061pmc: PMC8537037pubmed: 34681719google scholar: lookup
  127. Mannerberg A, Konradsson E, Kügele M, Edvardsson A, Kadhim M, Ceberg C, Peterson K, Thomasson H, Arendt ML, Børresen B. Surface Guided Electron FLASH Radiotherapy for Canine Cancer Patients. Med Phys 2023;50:4047–4054.
    doi: 10.1002/mp.16453pubmed: 37190907google scholar: lookup
  128. Eling L, Kefs S, Keshmiri S, Balosso J, Calvet S, Chamel G, Drevon-Gaud R, Flandin I, Gaudin M, Giraud L. Neuro-Oncologic Veterinary Trial for the Clinical Transfer of Microbeam Radiation Therapy: Acute to Subacute Radiotolerance after Brain Tumor Irradiation in Pet Dogs. Cancers 2024;16:2701.
    doi: 10.3390/cancers16152701pmc: PMC11311398pubmed: 39123429google scholar: lookup
  129. Dunfield E, Turek M, Buhr K, Christensen N. A Survey of Stereotactic Radiation Therapy in Veterinary Medicine. Vet Radiol Ultrasound 2018;59:786–795.
    doi: 10.1111/vru.12671pmc: PMC6218303pubmed: 30062728google scholar: lookup
  130. Nolan MW, Kent MS, Boss M-K. Emerging Translational Opportunities in Comparative Oncology With Companion Canine Cancers: Radiation Oncology. Front Oncol 2019;9:1291.
    doi: 10.3389/fonc.2019.01291pmc: PMC6883487pubmed: 31824863google scholar: lookup
  131. Gaudreault M, Chang D, Hardcastle N, Jackson P, Kron T, Hofman M. Combined Biology-Guided Radiotherapy and Lutetium PSMA Theranostics Treatment in Metastatic Castrate-Resistant Prostate Cancer. Front Oncol 2023;13:1134884.
    doi: 10.3389/fonc.2023.1134884pmc: PMC10040757pubmed: 36994211google scholar: lookup
  132. Konradsson E, Szecsenyi R, Adrian G, Coskun M, Børresen B, Arendt M. Evaluation of Intensity-modulated Electron FLASH Radiotherapy in a Clinical Setting Using Veterinary Cases. Med Phys 2023;50:6569–6579.
    doi: 10.1002/mp.16737pubmed: 37696040google scholar: lookup

Citations

This article has been cited 0 times.